Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber

Journal of Allergy and Clinical Immunology

Volumn 136, Issue 1, 2015, Pages 96-103.e9

  Werfel, Thomas ^a   Heratizadeh, Annice ^a   Niebuhr, Margarete ^a   Kapp, Alexander ^a   Roesner, Lennart Matthias ^a   Karch, Annika ^a   Erpenbeck, Veit J ^b   Losche, Christian ^b   Jung, Thomas ^b   Krug, Norbert ^c,d   Badorrek, Philipp ^c   Hohlfeld, Jens M ^c,d  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NOVARTIS PHARMA AG   (Switzerland)

^c FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^d German Centre for Lung Research   (Germany)

Author keywords

Atopic dermatitis; environmental challenge chamber; exposure; grass pollen; inhalant allergen

Indexed keywords

CCL1 CHEMOKINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 22; INTERLEUKIN 31; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; MACROPHAGE DERIVED CHEMOKINE; PLACEBO; POLLEN ANTIGEN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; ALLERGEN;

ADULT; AIR; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTACT SENSITIZATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DACTYLIS GLOMERATA; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ECZEMA; ENVIRONMENTAL CHALLENGE CHAMBER; ENVIRONMENTAL EXPOSURE; FEMALE; GRASS POLLEN; HUMAN; IMMUNE FUNCTION TEST; IMMUNOASSAY; INTERVENTION STUDY; LUMINEX BASED IMMUNOASSAY; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PRURITUS; REACTION ANALYSIS; SCORING OF ATOPIC DERMATITIS; SKIN DISEASE ASSESSMENT; SKIN MANIFESTATION; ADVERSE EFFECTS; AIR QUALITY CONTROL; BLOOD; DACTYLIS; IMMUNOLOGY; POLLEN; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADULT; ALLERGENS; ATMOSPHERE EXPOSURE CHAMBERS; CHEMOKINE CCL17; CHEMOKINE CCL22; DACTYLIS; DERMATITIS, ATOPIC; DISEASE PROGRESSION; ECZEMA; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-4; MALE; POLLEN; PRURITUS; YOUNG ADULT;

EID: 84937023045     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.04.015     Document Type: Article

References (41)

1. Werfel T. The role of leukocytes, keratinocytes, and allergen-specific IgE in the development of atopic dermatitis. J Invest Dermatol 2009;129:1878-91.
2. Ring J, Mohrenschlager M, Weidinger S. Molecular genetics of atopic eczema. Chem Immunol Allergy 2012;96:24-9.
3. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006;38:441-6.
4. Weidinger S, Baurecht H, Wagenpfeil S, Henderson J, Novak N, Sandilands A, et al. Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk. J Allergy Clin Immunol 2008;122:560-8.e4.
5. Fortugno P, Furio L, Teson M, Berretti M, El Hachem M, Zambruno G, et al. The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis. Hum Mol Genet 2012;21: 4187-200.
6. Werfel T, Kapp A. Environmental and other major provocation factors in atopic dermatitis. Allergy 1998;53:731-9.
7. Bieber T, Novak N. Pathogenesis of atopic dermatitis: new developments. Curr Allergy Asthma Rep 2009;9:291-4.
8. Heratizadeh A, Wichmann K, Werfel T. Food allergy and atopic dermatitis: how are they connected? Curr Allergy Asthma Rep 2011;11:284-91.
9. Heratizadeh A, Mittermann I, Balaji H, Wichmann K, Niebuhr M, Valenta R, et al. The role of T-cell reactivity towards the autoantigen alpha-NAC in atopic dermatitis. Br J Dermatol 2011;164:316-24.
10. Niebuhr M, Scharonow H, Gathmann M, Mamerow D, Werfel T. Staphylococcal exotoxins are strong inducers of IL-22: a potential role in atopic dermatitis. J Allergy Clin Immunol 2010;126:1176-83.e4.
11. Akdis CA, Akdis M. Immunological differences between intrinsic and extrinsic types of atopic dermatitis. Clin Exp Allergy 2003;33:1618-21.
12. Darsow U, Laifaoui J, Kerschenlohr K, Wollenberg A, Przybilla B, Wuthrich B, et al. The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy 2004;59:1318-25.
13. Walker WF. Some relation between our health and our environment: a study of the prevalence of disease in the city of Detroit with special reference to the influence of the type and sanitation of dwellings upon disease. Am J Public Health (N Y) 1923; 13:897-914.
14. Schafer T, Heinrich J, Wjst M, Adam H, Ring J, Wichmann HE. Association between severity of atopic eczema and degree of sensitization to aeroallergens in schoolchildren. J Allergy Clin Immunol 1999;104:1280-4.
15. Kramer U, Weidinger S, Darsow U, Mohrenschlager M, Ring J, Behrendt H. Seasonality in symptom severity influenced by temperature or grass pollen: results of a panel study in children with eczema. J Invest Dermatol 2005;124:514-23.
16. Rost GA. Über Erfahrungen mit der allergenfreien Kammer nach Storm van Leeuwen; insbesondere in der Spätperiode der exsudativen Diathese. Arch Dermatol Syphilol 1928;155:297-308.
17. Storm van Leeuwen W, Tissot van Patot PN. Allergenfreie Kammern in Privatwohnungen. Klinische Wochenschrift 1929;8:986-8.
18. Turjanmaa K. The role of atopy patch tests in the diagnosis of allergy in atopic dermatitis. Curr Opin Allergy Clin Immunol 2005;5:425-8.
19. Hohlfeld JM, Holland-Letz T, Larbig M, Lavae-Mokhtari M, Wierenga E, Kapsen-berg M, et al. Diagnostic value of outcome measures following allergen exposure in an environmental challenge chamber compared with natural conditions. Clin Exp Allergy 2010;40:998-1006.
20. Oranje AP, Stalder JF, Taieb A, Tasset C, de Longueville M. Scoring of atopic dermatitis by SCORAD using a training atlas by investigators from different disciplines. ETAC Study Group. Early Treatment of the Atopic Child. Pediatr Allergy Immunol 1997;8:28-34.
21. Schoefer Y, Schafer T, Meisinger C, Wichmann HE, Heinrich J. Predictivity of allergic sensitization (RAST) for the onset of allergic diseases in adults. Allergy 2008;63:81-6.
22. Reekers R, Busche M, Wittmann M, Kapp A, Werfel T. Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J Allergy Clin Immunol 1999;104:466-72.
23. Tuft L, Tuft HS, Heck VM. Atopic dermatitis; an experimental clinical study of the role of inhalant allergens. J Allergy 1950;21:181-6.
24. Tupker RA, De Monchy JG, Coenraads PJ, Homan A, van der Meer JB. Induction of atopic dermatitis by inhalation of house dust mite. J Allergy Clin Immunol 1996; 97:1064-70.
25. Werfel T, Ballmer-Weber B, Eigenmann PA, Niggemann B, Rance F, Turjanmaa K, et al. Eczematous reactions to food in atopic eczema: position paper of the EAACI and GA2LEN. Allergy 2007;62:723-8.
26. Brinkman L, Aslander MM, Raaijmakers JA, Lammers JW, Koenderman L, Bruijnzeel-Koomen CA. Bronchial and cutaneous responses in atopic dermatitis patients after allergen inhalation challenge. Clin Exp Allergy 1997;27:1043-51.
27. Oppel T, Schuller E, Gunther S, Moderer M, Haberstok J, Bieber T, et al. Phenotyping of epidermal dendritic cells allows the differentiation between extrinsic and intrinsic forms of atopic dermatitis. Br J Dermatol 2000;143:1193-8.
28. Rho NK, Kim WS, Lee DY, Lee JH, Lee ES, Yang JM. Immunophenotyping of inflammatory cells in lesional skin of the extrinsic and intrinsic types of atopic dermatitis. Br J Dermatol 2004;151:119-25.
29. Sicherer SH, Leung DY. Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2010. J Allergy Clin Immunol 2011;127:326-35.
30. Boralevi F, Hubiche T, Leaute-Labreze C, Saubusse E, Fayon M, Roul S, et al. Epicutaneous aeroallergen sensitization in atopic dermatitis infants-determining the role of epidermal barrier impairment. Allergy 2008;63:205-10.
31. Jinnestal CL, Belfrage E, Back O, Schmidtchen A, Sonesson A. Skin barrier impairment correlates with cutaneous Staphylococcus aureus colonization and sensitization to skin-associated microbial antigens in adult patients with atopic dermatitis. Int J Dermatol 2014;53:27-33.
32. Pennino D, Eyerich K, Scarponi C, Carbone T, Eyerich S, Nasorri F, et al. IL-17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes. J Immunol 2010;184:4880-8.
33. Bilsborough J, Leung DY, Maurer M, Howell M, Boguniewicz M, Yao L, et al. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol 2006;117: 418-25.
34. Sharquie IK, Al-Ghouleh A, Fitton P, Clark MR, Armour KL, Sewell HF, et al. An investigation into IgE-facilitated allergen recognition and presentation by human dendritic cells. BMC Immunol 2013;14:54.
35. Hijnen D, De Bruin-Weller M, Oosting B, Lebre C, De Jong E, Bruijnzeel-Koomen C, et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 2004;113:334-40.
36. Kwon YS, Oh SH, Wu WH, Bae BG, Lee HJ, Lee MG, et al. CC chemokines as potential immunologic markers correlated with clinical improvement of atopic dermatitis patients by immunotherapy. Exp Dermatol 2010;19:246-51.
37. Robinson D, Hamid Q, Bentley A, Ying S, Kay AB, Durham SR. Activation of CD41 T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993;92:313-24.
38. Badorrek P, Dick M, Emmert L, Schaumann F, Koch W, Hecker H, et al. Pollen starch granules in bronchial inflammation. Ann Allergy Asthma Immunol 2012; 109:208-14.e6.
39. Williams HC, Burney PG, Pembroke AC, Hay RJ. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol 1994;131:406-16.
40. Krug N, Hohlfeld JM, Larbig M, Buckendahl A, Badorrek P, Geldmacher H, et al. Validation of an environmental exposure unit for controlled human inhalation studies with grass pollen in patients with seasonal allergic rhinitis. Clin Exp Allergy 2003;33:1667-74.
41. Hohlfeld JM, Holland-Letz T, Larbig M, Lavae-Mokhtari M, Wierenga E, Kapsenberg M, et al. Diagnostic value of outcome measures following allergen exposure in an environmental challenge chamber compared with natural conditions. Clin Exp Allergy 2010;40:998-1006.